Antifungal Activity of Homoaconitate and Homoisocitrate Analogs
AbstractThirteen structural analogs of two initial intermediates of the L-a-aminoadipate pathway of L-lysine biosynthesis in fungi have been designed and synthesized, including fluoro- and epoxy-derivatives of homoaconitate and homoisocitrate. Some of the obtained compounds exhibited at milimolar range moderate enzyme inhibitory properties against homoaconitase and/or homoisocitrate dehydrogenase of Candida albicans. The structural basis for homoisocitrate dehydrogenase inhibition was revealed by molecular modeling of the enzyme-inhibitor complex. On the other hand, the trimethyl ester forms of some of the novel compounds exhibited antifungal effects. The highest antifungal activity was found for trimethyl trans-homoaconitate, which inhibited growth of some human pathogenic yeasts with minimal inhibitory concentration (MIC) values of 16–32 mg/mL. View Full-Text
Share & Cite This Article
Milewska, M.J.; Prokop, M.; Gabriel, I.; Wojciechowski, M.; Milewski, S. Antifungal Activity of Homoaconitate and Homoisocitrate Analogs. Molecules 2012, 17, 14022-14036.
Milewska MJ, Prokop M, Gabriel I, Wojciechowski M, Milewski S. Antifungal Activity of Homoaconitate and Homoisocitrate Analogs. Molecules. 2012; 17(12):14022-14036.Chicago/Turabian Style
Milewska, Maria J.; Prokop, Marta; Gabriel, Iwona; Wojciechowski, Marek; Milewski, Sławomir. 2012. "Antifungal Activity of Homoaconitate and Homoisocitrate Analogs." Molecules 17, no. 12: 14022-14036.